Brain Cancer
Glioma Study Unravels Molecular Features of Tumors From Adolescent, Young Adult Patients
Individuals with low-grade tumors and pediatric glioma-like alterations tended to have better progression-free survival and overall outcomes than others.
Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.
The firm is using single-cell, multiomics analysis to probe tumor samples from very long-term cancer survivors for keys to defeating the disease.
Denovo, Anova Begin Brain Cancer Gene Therapy Trial Involving Response Biomarker
In an earlier study, patients with biomarker-positive high-grade glioma lived longer after treatment with DB107 than biomarker-negative patients.
FDA Grants Priority Review to Chimerix for Dordaviprone in H3 K27M-Mutant Diffuse Glioma
In a Phase III trial, 28 percent of newly diagnosed patients with H3 K27M-mutant diffuse glioma responded to treatment with dordaviprone.